Dataset from A Multicentre, Randomised, Double-blind, Placebo-Controlled Phase 3 Extension Study to Characterise the Long-term Safety and Tolerability of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus.
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00009324
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to characterise long-term safety and tolerability of intravenous
anifrolumab.
创建时间：
2025-11-21
